54 results
Latest MEAs  
Latest MEAs MeshMEA Find more about our Mesh MEAs: www.nmi.de/en/disease-models-and-mechanisms/research-development/mesh-meas-for-organoids  
Service for Pharma  
Service for Pharma We are an established provider of non-clinical contract research services, with a long-standing CRO track record with numerous small, medium, and large pharma and biotech…  
Custom Cell Services  
Custom Cell Services A key focus of our contract research service portfolio is on advanced cell-based assays, novel and better cell models, and custom cell lines, such that our clients and partners…  
Immuno-Oncology Assay Services  
Immuno-Oncology Assay Services Through extensive analysis of a growing number of patient-derived microtumours (PDMs) from diverse cancer types - together with autologous TILs and PBMCs - we have…  
MEA Neurosensor  
MEA Neurosensor Services: neurobiology studies and neurotoxicity assesment More content coming soon. In case of interest, please, contact us. Publications Loser D, Danker T, Möller C,…  
MEA Cardiosensor  
MEA Cardiosensor Services: testing drug effects on cardiac function Our Cardiosensor is a reliable and rapid system to test for drug effects on cardiac function, including QT-interval…  
MEA-Based Services  
MEA-Based Services MEA (microelectrode array) offers extracellular recording with optional optical or electrical stimulation. It is performed on electrogenic tissue on the top of…  
Cav1.2 Cell Line  
Our proprietary Cav1.2 Cell Line Host cell: CHO-K1 Platforms: Fluorescence, QPatch Tested reference inhibitors: Nifedipine, Verapamil, Isradipine Tested reference activators: FPL64176 Cav1.2…  
Cell Models  
Electrophysiology cell models expertise Cell models developed for your studies - depending on what you need, we will offer you the right cell model developed with long-standing expertise. …  
Target Systems  
Get classic and modern approaches to cardiac safety studies: Standard FDA guideline S7B compliant hERG screening, Cardiac ion channels, hiPSC cardiomyocyte studies, latest…